Evidence map›Paper›PMID 35436413›Full record

ReviewAnnual review of neuroscience2022

Microglia and Neurodevelopmental Disorders.

John R Lukens, Ukpong B Eyo

Open access · bronzeAbstract readReview
In one paragraph

Review in Annual review of neuroscience, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 98 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
98citing papers in PubMed, 1 pooled it
12.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

98 citing papers in PubMed, 1 synthesis or guideline pooled it, 160 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Schizophrenia: from mechanism to therapy.Science China. Life sciences · 2026
    Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. [Volatile oil fromNan fang yi ke da xue xue bao = Journal of Southern Medical University · 2026
    Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

38 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

John R LukensDepartment of Neuroscience, University of Virginia School of Medicine, Charlottesville, Virginia, USA; email: ube9q@virginia.edu.
Ukpong B EyoDepartment of Neuroscience, University of Virginia School of Medicine, Charlottesville, Virginia, USA; email: ube9q@virginia.edu.
University of Virginia · US

Funding

Targeting Microglia in Febrile Status EpilepticusR01NS119243 · NINDS · UNIVERSITY OF VIRGINIA · PI EYO, UKPONG BASSEY · 2021 to 2025
$2.4M
Microglial-Neurovascular Dynamics and Regulation of Neurovascular Structure and FunctionR01NS122782 · NINDS · UNIVERSITY OF VIRGINIA · PI EYO, UKPONG BASSEY · 2021 to 2025
$2.0M
Inflammasome activation and lymphatic dysfunction in traumatic brain injuryR01NS106383 · NINDS · UNIVERSITY OF VIRGINIA · PI LUKENS, JOHN R · 2018 to 2022
$1.8M
Microglial P2Y12 Receptors in Normal Developmental Physiology and SeizuresK22NS104392 · NINDS · UNIVERSITY OF VIRGINIA · PI EYO, UKPONG BASSEY · 2017 to 2020
$813k
Delineating the effects of sex on microglia in neurodevelopmental disordersR21MH120412 · NIMH · UNIVERSITY OF VIRGINIA · PI LUKENS, JOHN R · 2019 to 2020
$440k
NIMH NIH HHS R21 MH120412NINDS NIH HHS K22 NS104392NINDS NIH HHS R01 NS106383NINDS NIH HHS R01 NS119243NINDS NIH HHS R01 NS122782
6 · The paper itself

Abstract

Mounting evidence indicates that microglia, which are the resident immune cells of the brain, play critical roles in a diverse array of neurodevelopmental processes required for proper brain maturation and function. This evidence has ultimately led to growing speculation that microglial dysfunction may play a role in neurodevelopmental disorder (NDD) pathoetiology. In this review, we first provide an overview of how microglia mechanistically contribute to the sculpting of the developing brain and neuronal circuits. To provide an example of how disruption of microglial biology impacts NDD development, we also highlight emerging evidence that has linked microglial dysregulation to autism spectrum disorder pathogenesis. In recent years, there has been increasing interest in how the gut microbiome shapes microglial biology. In the last section of this review, we put a spotlight on this burgeoning area of microglial research and discuss how microbiota-dependent modulation of microglial biology is currently thought to influence NDD progression.

Indexed as

Autism Spectrum DisorderGastrointestinal MicrobiomeNeurodevelopmental DisordersBrainHumansMicrogliaautismmicrobiomemicroglianeurodevelopmental disordersRett syndrome

Identifiers

PMID35436413
PMCPMC10449242
OpenAlexW4224279191

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.